179250-28-3 Usage
Description
TERT-BUTYL 4-[2-(HYDROXYMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is a versatile chemical compound characterized by its molecular structure that includes a tert-butyl group, a 2-(hydroxymethyl)phenyl group, and a tetrahydro-1(2H)-pyrazinecarboxylate group. It is recognized for its reactivity and potential pharmacological properties, making it a valuable building block in organic synthesis and pharmaceutical research.
Uses
Used in Pharmaceutical Research:
TERT-BUTYL 4-[2-(HYDROXYMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is used as a pharmaceutical intermediate for its potential to contribute to the development of new drugs and biologically active molecules. Its unique structure and reactivity allow for the creation of diverse therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, TERT-BUTYL 4-[2-(HYDROXYMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE serves as a key component in the synthesis of complex organic molecules. Its ability to react with various other compounds makes it instrumental in the production of specialty chemicals and materials.
Used in Therapeutic Applications:
TERT-BUTYL 4-[2-(HYDROXYMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is used as a precursor in the formulation of therapeutic agents, given its potential pharmacological properties. It is being explored for its role in various medicinal applications, highlighting its importance in advancing healthcare solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 179250-28-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,2,5 and 0 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 179250-28:
(8*1)+(7*7)+(6*9)+(5*2)+(4*5)+(3*0)+(2*2)+(1*8)=153
153 % 10 = 3
So 179250-28-3 is a valid CAS Registry Number.
InChI:InChI=1/C16H24N2O3/c1-16(2,3)21-15(20)18-10-8-17(9-11-18)14-7-5-4-6-13(14)12-19/h4-7,19H,8-12H2,1-3H3
179250-28-3Relevant articles and documents
(2-benzylphenyl)piperazine derivatives and use thereof
-
, (2019/11/19)
The invention discloses (2-benzylphenyl)piperazine derivatives, a use thereof, and a medicinal composition comprising above compounds. The derivatives and the medicinal composition are used for inhibiting serotonin reuptake. The invention also relates to
Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands
Marinkovic, Dragan,Tucci, Fabio C.,Tran, Joe A.,Fleck, Beth A.,Wen, Jenny,Chen, Chen
scheme or table, p. 4817 - 4822 (2009/05/26)
A series of piperazinebenzylalcohols were prepared and studied to compare with their ketone and amine analogs as MC4R antagonists. Several benzylalcohols such as 14a and 14g displayed low nanomolar binding affinities (Ki 10 nM), and high sele
Aryl piperazine melanocortin MC4 receptor agonists
Dyck, Brian,Parker, Jessica,Phillips, Teresa,Carter, Lee,Murphy, Brian,Summers, Robin,Hermann, Julia,Baker, Tracy,Cismowski, Mary,Saunders, John,Goodfellow, Val
, p. 3793 - 3796 (2007/10/03)
Incorporation of substituted phenyl piperazine privileged structures into a known MC4 specific dipeptoid consensus sequence resulted in a series of potent (EC50=24 nM) and selective MC4-R agonists. We report the SAR of this series of compounds
